Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Clinical Utility of Antipeptidyl Arginine Deiminase Type 4 Antibodies.

Darrah E, Martinez-Prat L, Mahler M.

J Rheumatol. 2019 Mar;46(3):329-330. doi: 10.3899/jrheum.180905. Epub 2019 Jan 15. No abstract available.

PMID:
30647163
2.

The Utilization of Autoantibodies in Approaches to Precision Health.

Fritzler MJ, Martinez-Prat L, Choi MY, Mahler M.

Front Immunol. 2018 Nov 16;9:2682. doi: 10.3389/fimmu.2018.02682. eCollection 2018.

3.

Antibodies targeting protein-arginine deiminase 4 (PAD4) demonstrate diagnostic value in rheumatoid arthritis.

Martinez-Prat L, Lucia D, Ibarra C, Mahler M, Dervieux T.

Ann Rheum Dis. 2019 Mar;78(3):434-436. doi: 10.1136/annrheumdis-2018-213818. Epub 2018 Oct 8. No abstract available.

PMID:
30297325
4.

Comparison of Serological Biomarkers in Rheumatoid Arthritis and Their Combination to Improve Diagnostic Performance.

Martinez-Prat L, Nissen MJ, Lamacchia C, Bentow C, Cesana L, Roux-Lombard P, Gabay C, Mahler M.

Front Immunol. 2018 Jun 6;9:1113. doi: 10.3389/fimmu.2018.01113. eCollection 2018.

Supplemental Content

Loading ...
Support Center